Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
about
Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicideDC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by plateletsStructural insights on the role of antibodies in HIV-1 vaccine and therapyFunctional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGNMutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer.Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection.N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.A decline in CCL3-5 chemokine gene expression during primary simian-human immunodeficiency virus infection.HIV-1 Transmission, Replication Fitness and Disease Progression.3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaquesMaleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission.V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaquesImmunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate.Phenotypic properties of transmitted founder HIV-1In vitro neutralization of low dose inocula at physiological concentrations of a monoclonal antibody which protects macaques against SHIV challenge.Adaptation of subtype a human immunodeficiency virus type 1 envelope to pig-tailed macaque cellsPeptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.Role of the human immunodeficiency virus type 1 envelope gene in viral fitness.Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodiesCD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaquesAntibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens.Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection.Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymusComparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.Repertoire comparison of the B-cell receptor-encoding loci in humans and rhesus macaques by next-generation sequencingControl of viremia and maintenance of intestinal CD4(+) memory T cells in SHIV(162P3) infected macaques after pathogenic SIV(MAC251) challenge.Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques.3-hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate against HIV type 1 entry by targeting both viral envelope glycoprotein gp120 and cellular receptor CD4.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodiesGrowth potentials of CCR5-tropic/CXCR4-tropic HIV-1mt clones in macaque cells.Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry.Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus VaccinesIncorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2.Development of SHIVs with circulating, transmitted HIV-1 variants.A Degraded Fragment of HIV-1 Gp120 in Rat Hepatocytes Forms Fibrils and Enhances HIV-1 Infection.A single gp120 residue can affect HIV-1 tropism in macaques.
P2860
Q24559813-5527A727-8C41-4796-9A1B-528B7C0ECE11Q24673797-BF1A119A-E32C-4D92-B932-9040CEAE56C3Q26829461-053A2B18-457C-4986-ABB3-234C93E6E131Q28590922-C0EC9ADD-050A-4406-AFE4-D8B0E92F1AF2Q30368471-988032BD-5C02-4672-945F-0BF5A8CB50ACQ30485614-25D0C683-FD4A-48E3-8FC3-908567594690Q33208281-DAC1A4AC-D049-498E-984F-96A6522F92B5Q33293538-9164CB0F-2141-472D-9FE0-5B5F82C0980DQ33758570-FA9E985F-7FDF-4090-AC5E-656DE3092852Q33826278-F42B79BA-13DD-44A8-8109-2D480B72B158Q33826773-A00F4E5A-108D-4A64-84DC-E5390193A18FQ33925615-8CABEE40-B6B7-4462-8DA9-64C13D96894AQ33984326-5686A49F-0FCB-450E-B706-38CBBC444ECAQ34120088-14942F99-B7A8-49D2-A329-52D0883ECFC5Q34186017-D02F3C0E-7212-462E-8FA9-D488493BDA9FQ34336058-E5BCD0B0-430D-4711-B2C5-111A630C892AQ34974016-DBBD97B7-0D38-4CDF-B2AE-7963348A8693Q35076897-9EA19FCB-9979-459D-AD17-57B2A8A25C31Q35077776-7E7CE59C-01A7-4D22-9A2A-1CAB3833014CQ35182388-ADB42A69-64D4-487D-A688-580B65660D39Q35857254-93132008-09A8-4B56-9C32-C697C85038B6Q35978751-08827849-6EB4-4DAC-BCE0-EDF3536118B6Q36141515-1374BFD2-EC8E-4D0D-8041-CEA51FAF8B02Q36171962-D01A1906-F4B8-49E4-9D5E-6AD2A9D9FA1DQ36397434-4B383D78-23CB-4A00-BCA8-99B1CCF4F9EDQ36958820-80BE0948-1626-43A5-93E2-5AC97FF0D185Q36981370-B1611F5B-3283-4316-B131-C1EA89ADFC58Q37151457-76B52213-75EF-4074-87C4-E3B65C28A6EDQ37171639-43AA66F9-6EB1-4B38-9CEF-8498D375AA13Q37192119-9D7344A9-6BFA-42F8-9711-FBBBF180EC6CQ37258274-2DE2460D-F639-4AE9-9E20-6EDFF7A3CD04Q37621530-967828B2-ED6D-452B-B97A-E0D52B67A4EEQ38975223-3378FF13-E613-4996-9700-34F7FFCC255BQ39021508-EF8908D2-8C4D-48A4-ACA7-9E71C398BA64Q39242155-8C09926A-D351-44A4-9E38-0B1A291DDB99Q39582556-6B03E0AD-3DFA-4AC9-BCA6-9B5FE88C4357Q39702629-1199FA2F-BBF4-4ED7-8920-20D3F8E25A91Q41144765-82F4B585-A7DA-43F5-AEE4-E66853AF8E60Q41924302-090B38B8-BCEC-471C-A81D-C606A0362427Q41930708-E8067F66-D165-41BF-8754-617D2CDB88D8
P2860
Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@ast
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@en
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@nl
type
label
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@ast
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@en
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@nl
prefLabel
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@ast
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@en
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@nl
P2093
P2860
P1433
P1476
Increased mucosal transmission ...... 162P3) maps to envelope gp120.
@en
P2093
Agegnehu Gettie
Cecilia Cheng-Mayer
Clarisa Buckner
James Blanchard
Janet M Harouse
P2860
P304
P356
10.1128/JVI.77.2.989-998.2003
P407
P577
2003-01-01T00:00:00Z